MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
Status:
Terminated
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2
Diabetes.
This is an early phase trial and some specific protocol information is in progress and not
publicly available at this time. (Full information is available to trial participants).